Humana forms two groups focused on population health

In an effort to help providers transition to value-based reimbursement models, Humana has formed two new organizations focused on population health.

Transcend will provide resources in care coordination, financial risk management, clinical integration and patient engagement that help physicians improve the patient experience as well as care outcomes, according to a release. Formerly known as the Humana Management Services Organization (MSO), Transcend collaborates with physicians, medical groups and integrated delivery systems to successfully transition to value-based care by engaging, partnering and offering practical services and solutions.

Transcend Insights represents the convergence of Humana subsidiaries Certify Data Systems, Anvita Health and nliven systems and provides healthcare systems, physicians and care teams with advanced community-wide interoperability, real-time analytics and care tools.  

Humana’s goal is to have 75 percent of its individual Medicare Advantage (MA) members covered under value-based relationships by 2017. The company’s investment strategy over the last few years has produced positive results in the form of stronger clinical models, enhanced brands focused on health, a consumer-centric approach, and industry-leading provider risk relationships.

Transcend Insights' HealthLogix platform last year helped users identify more than 36 million opportunities for care improvement, including 557,000 opportunities to impact drug safety, and 2.3 million opportunities to increase medication adherence.

Transcend Insights will demonstrate its HealthLogix platform  at the HIMSS15 Annual Conference and Exhibition in Chicago at booth 2048.

 

Beth Walsh,

Editor

Editor Beth earned a bachelor’s degree in journalism and master’s in health communication. She has worked in hospital, academic and publishing settings over the past 20 years. Beth joined TriMed in 2005, as editor of CMIO and Clinical Innovation + Technology. When not covering all things related to health IT, she spends time with her husband and three children.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.